Federal officials reverse limits on fetal tissue research
Federal officials have reversed Trump administration restrictions on using human fetal tissue for medical research
Federal officials on Friday reversed Trump administration restrictions on using human fetal tissue for medical research.
The changes clear the way for using government money on work that in the past has led to treatments for a variety of diseases, including COVID-19.
Government scientists now will be able to resume research that uses tissue from elective abortions. Scientists at universities also can now apply for federal grants without getting approval from a special ethics panel for any such work.
Those provisions include following applicable laws, such as obtaining informed consent from anyone donating such tissue. The changes were detailed in a notice to researchers.
Two dozen members of Congress who had written to Becerra urging the change praised the move. The restrictions were “politically motivated and unnecessary,” they wrote earlier this week.
The American Society of Reproductive Medicine also issued a statement applauding the change. “The United States government has developed a robust system of oversight. …. Ideologically driven politicians must not be allowed to interfere with this system on a whim,” the group said.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.